Stephanie Price

On August 9 the U.S Food and Drug Administration rejected Lykos Therapeutics' New Drug Application (NDA) for MDMA-assisted psychotherapy. However, the journey to approval is not over yet, and Lykos is now working to address the issues that led to the rejection.

Drug Science and University College London (UCL) are joining forces in a new collaboration that seeks to address concerns over the therapy component of MDMA-assisted psychotherapy in light of the recent U.S. Food and Drug Administration (FDA) rejection.

A damning report into the state of the NHS has called for a major overhaul, highlighting how technology in the service lags 15 years behind the private sector.

New research used intracranial electroencephalography (icEEG) tests – where small electrodes are inserted into the substance of the brain to measure electrical impulses – to track the brain activity of nine patients being evaluated for surgical treatment of medication-resistant epilepsy.

A first-of-its-kind study has revealed that millions of Americans could benefit from psilocybin therapy if approved by the U.S. Food and Drug Administration.

A six-month follow-up study of a Phase 2 clinical trial investigating psilocybin versus escitalopram for the treatment of major depressive disorder has shown positive results.

For the first time, a government-funded UK trial will investigate psilocybin-assisted psychotherapy for targetting relapses associated with opioid addiction, aiming to bring an innovative new therapy to the NHS if successful.

There is no simple solution in the fight against online child sexual abuse but modern technology may be able to play a part.

A new report by the UK's Women and Equalities Committee (WEC) that focusses on women's reproductive health has warned that women are being left undiagnosed and in unnecessary pain for years.

The U.S National Library of Medicine (NLM) and the Office of Research on Women's Health (ORWH) have launched the Discover Women's Health (DiscoverWHR) Resource which aims to close the gaps in women's health research and care.